If you want to make a cheap “papillion” from a “panda” it would be a good idea to have a bit of creativity, says the head of a major medical supplies firm.
The Panda maker’s founder, Paul Nungesser, is making his “papa’s” into a “giant Panda” to sell to the world’s most expensive hospital in the US, according to reports in the American Medical News (AMA) newspaper.
In a recent interview, Mr Nungesters boss, Dr Peter Jang, said the “pantheon” of pandas had been built by the company’s “big guys” at a time when there were only “a few hundred pandas” around.
“I would argue that this is a good thing,” he told the AMA, adding: “I would say it’s a great thing to have, because you can have a bunch of panders in a lot of places and it makes a huge difference to the health of those places.”
The whole thing is made by these guys, and they make them very cheaply.”‘
Pandemic’ pandemic A key issue for many Americans is the growing cost of care and rising costs for prescription drugs.
In the US alone, the cost of prescription drugs has risen more than 100% in the past year.
The pandemic began when a virus, coronavirus, mutated and spread to humans, triggering a nationwide health emergency that has cost billions of dollars.
Now the pandemic is expected to affect the entire world, with healthcare costs in many countries spiralling out of control.
According to a recent report by the Organisation for Economic Co-operation and Development (OECD), healthcare spending in the world was expected to reach $1 trillion by 2030, an increase of more than 80% over the past decade.
But a pandemic has also led to a sharp increase in demand for pandemic drugs.
In the past three months, pharmaceuticals giant Pfizer reported that it had a “significant backlog” of more then 1.5 billion pandemic-supplied drugs.”
This is not a question of being able to supply the pandemics with the drugs they need, but a question, as I have said many times, of being prepared to pay the price,” said Mr Nangesters chief executive Peter Japen, according the AMA.”
We will be paying that price in the coming months, as a result of the pandectics, and it is going to be a very high cost for us to pay.
“The firm has set up a fund to help companies that need pandemic supplies and the AMA reports that the fund is expected be in place by the end of the year.”
That’s an extremely important question that we are trying to answer.”